Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer
Cancer driver mutations can occur within noncoding genomic sequences. Here, the authors develop a statistical approach to identify candidate noncoding driver mutations in DNase I hypersensitive sites in breast cancer and experimentally demonstrate they are regulatory elements of known cancer genes.
Guardado en:
Autores principales: | Matteo D′Antonio, Donate Weghorn, Agnieszka D′Antonio-Chronowska, Florence Coulet, Katrina M. Olson, Christopher DeBoever, Frauke Drees, Angelo Arias, Hakan Alakus, Andrea L. Richardson, Richard B. Schwab, Emma K. Farley, Shamil R. Sunyaev, Kelly A Frazer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fed8c71471284e789fe9fe3936d957c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genome-wide prediction of DNase I hypersensitivity using gene expression
por: Weiqiang Zhou, et al.
Publicado: (2017) -
Correlation between DNase I hypersensitive site distribution and gene expression in HeLa S3 cells.
por: Ya-Mei Wang, et al.
Publicado: (2012) -
Genome-wide mapping of DNase I hypersensitive sites reveals chromatin accessibility changes in Arabidopsis euchromatin and heterochromatin regions under extended darkness
por: Yue Liu, et al.
Publicado: (2017) -
Germline de novo mutation rates on exons versus introns in humans
por: Miguel Rodriguez-Galindo, et al.
Publicado: (2020) -
Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling
por: Daniela Egli-Spichtig, et al.
Publicado: (2021)